Abstract Details

Title Length of Stay and Mortality of Patients with Intracerebral Hemorrhage in a Tertiary Center in the Dominican Republic: A Single Center Analysis.

Topic Cerebrovascular Disease and Interventional Neurology

Presentation(s) P11 - Poster Session 11 (11:45 AM-12:45 PM)

Poster/Presentation
Number 5-002

Objective To estimate the length of hospital stay and mortality among patients with intracerebral hemorrhage admitted to José María Cabral y Báez Hospital, between January 2024 and January 2025

Background ICH represents the second most frequent type of stroke worldwide, accounting for nearly 10–15% of all cases. ICH is associated with higher morbidity and mortality rates. Survivors often face severe neurological deficits and long-term disability, creating a substantial burden for patients, families, and healthcare systems. In this study, we aimed to evaluate determinants of short-term prognosis and recovery in patients with acute ICH, seeking to strengthen clinical decision-making in acute care.

Design/Methods A retrospective study including 156 patients diagnosed with intracerebral hemorrhage admitted to José María Cabral y Báez Hospital between January 2024 and January 2025. Sociodemographic and clinical data were obtained from medical records. Cases were selected through non-probability convenience sampling.

Results 156 patients were included, of whom 21% died. Male patients accounted for 13.4%. Mortality according to hospital stay was 35% for patients admitted ≤2 days, 39% for 3–7 days, 23% for 8–15 days. Patients with NIHSS scores of 21–42 had a mortality of 56%. Intraventricular hemorrhage was associated with 6% mortality, brainstem hemorrhage with 19%, lobar hemorrhage with 31%, and basal ganglia hemorrhage with 34%. Among these, patients who required intraventricular drainage had a mortality of 63%. Mortality by GCS was 56% for GCS 3–8.

Conclusions Higher mortality was observed in male patients, patients hospitalized for 3–7 days, patients with hemorrhage located in the basal ganglia, and admission GCS scores between 3–8. Mortality also increased with higher NIHSS scores, particularly in patients scoring 21–42. This study reveals novel data on complications and mortality within the Dominican Republic’s National Public Health System, which will contribute to the development of preventive measures and treatments to mitigate the complications associated with this devastating neurological emergencies.

Authors/Disclosures
Ryna Then, MD (Jefferson Einstein Hospital) PRESENTER	Dr. Then has nothing to disclose.
Cristina E. Ramos, MD	Dr. Ramos has nothing to disclose.
Genesis Polanco Jerez, MD (Hospital José Maria Cabral y Baez)	Dr. Polanco Jerez has nothing to disclose.
Raquel Monegro Cordero, Estudiante	Mrs. Monegro Cordero has nothing to disclose.
Jamila Mercedes, Sr., PhD	No disclosure on file
Henry L. Alvarez, MD	Dr. Alvarez has nothing to disclose.
Yaritza Bautista Estrella, PhD	Dr. Bautista Estrella has nothing to disclose.
Dorisbel A. Grullon, Sr., MD	Dr. Grullon has nothing to disclose.
Yvan Mercader, MD (Clinica Dr.Bonilla)	Dr. Mercader has nothing to disclose.
Bruno A. Rosario, MD (Union Medica del Norte)	Dr. Rosario has nothing to disclose.
Biany Santos de Pena, MD	Dr. Santos de Pena has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche, Mesofarma Corporation y Novartis .
Ana M. Rodriguez, MD (Turenlaces del Caribe)	Dr. Rodriguez has nothing to disclose.
Karen Espinal (Hospital Regional Universitario Jose María Cabral y Báez, Santiago, Dominican Republic)	Karen Espinal has nothing to disclose.
Marcos M. Mota, Sr., Br	Mr. Mota has nothing to disclose.
Maria G. Munoz, Br	Mrs. Munoz has nothing to disclose.
Michele Hernandez, MD	Dr. Hernandez has nothing to disclose.

��ɫ��

��ɫ��